|
Market Closed -
Euronext Paris
19:55:00 30/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 0.0953 EUR | -1.24% |
|
-0.83% | -99.89% |
| 06-30 | Neovacs bolsters its strategic intellectual property portfolio |  |
| 04-30 | Neovacs S.A. Auditor Raises 'Going Concern' Doubt | CI |
Company Valuation: NEOVACS
Data adjusted to current consolidation scope
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Market Cap 1 | - | - | - | - | - | - |
| Change | - | - | - | - | - | - |
| Enterprise Value (EV) 1 | - | - | - | - | - | - |
| Change | - | - | - | - | - | - |
| P/E | -96,912,987x | -264,999,452x | -6,728x | -22,860,253x | - | - |
| PBR | - | - | - | - | - | - |
| PEG | - | 3,273,301.5x | -0x | 229,169x | - | - |
| Capitalization / Revenue | - | - | - | - | - | - |
| EV / Revenue | - | - | - | - | - | - |
| EV / EBITDA | - | - | - | - | - | - |
| EV / EBIT | - | - | - | - | - | - |
| EV / FCF | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -0.0479 | -0.009117 | -5.946 | -0.0147 | - | - |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | 0.0952 | 0.031 | 0.0225 | 0.001112 | 0.5334 | 0.4339 |
| EBITDA 1 | -8.118 | -3.437 | -7.728 | -6.294 | -6.06 | -6.43 |
| EBIT 1 | -8.175 | -3.492 | -7.828 | -6.445 | -6.908 | -6.622 |
| Net income 1 | -7.548 | -6.143 | -11.84 | -3.549 | -8.743 | -32.91 |
| Net Debt 1 | -1.234 | -9.681 | -32.06 | -5.555 | -0.2365 | -0.2051 |
| Reference price 2 | 4,640,000.0000 | 2,416,000.0000 | 40,000.0000 | 336,000.0000 | 20,000.0000 | 10,212,000.0000 |
| Nbr of stocks (in thousands) | - | - | - | - | - | - |
| Announcement Date | 4/30/20 A | 6/29/21 A | 5/2/22 A | 4/30/23 A | 4/30/24 A | 4/30/25 A |
1EUR in Million2EUR
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 17.14K | |
| 16.97x | 6.42x | 12.3x | 1.76% | 64.38B | |
| 30.03x | 8.21x | 26.91x | 0.04% | 56.16B | |
| 37.32x | 6.62x | 19.78x | 0.87% | 54.16B | |
| 35.94x | 3.4x | 14.66x | -.--% | 45.33B | |
| 49.01x | 5.65x | 30.93x | -.--% | 42.25B | |
| -19.75x | 191.25x | -21.04x | -.--% | 40.78B | |
| 46.05x | 8.16x | 27.33x | -.--% | 33.8B | |
| 31.61x | 8.04x | 20.91x | 0.41% | 32.25B | |
| 27.18x | 5.72x | 14.84x | -.--% | 23.57B | |
| Average | 28.26x | 27.05x | 16.29x | 0.34% | 39.27B | |
| Weighted average by Cap. | 27.79x | 25.71x | 16.39x | 0.45% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- ALNEV Stock
- Valuation NEOVACS
Select your edition
All financial news and data tailored to specific country editions
